*RUSM has a first-time residency attainment rate of 96%, calculated as the percent of students attaining a 2025-26 residency position out of graduates or expected graduates in 2024-25 who were active applicants in the 2025 NRMP match or who attained a residency position outside the NRMP match. AUC’s first-time residency attainment rate for 2024-2025 graduates and expected graduates is 95%. SABA’s four-year residency placement rate of 97% is calculated as the percent of students attaining a residency position out of all graduates or expected graduates in 2020-21, 2021-22, 2022-23 and 2023-24 who were active applicants in the NRMP match or attained a residency outside the NRMP match. As of July 17, 2025, they have not published their 2025 rates. SGU’s US residency placement rate of 94% pertains to graduates over five years from 2021, 2022, 2023, 2024, and 2025 with the rate calculated as the total number of students/graduates who obtained a US residency divided by the total number of students/graduates who applied to a US residency program in a given year as of April 2025.
Congratulations to MS4 student Brittany Maner for her recent publication The Magnitude of COVID-19’s Effect on the Timely Management of Melanoma and Nonmelanoma Skin Cancers in the April edition of the Journal of the American Academy of Dermatology on ScienceDirect.
Due to various dermatologic conditions Brittany suffered as a child, she became interested in the field of dermatology and discovered there was more depth than the average person believes, “I realized that dermatology was so much more than just acne, psoriasis and atopic dermatitis management. It was more than cosmetic dermatology. It was surgery, cutaneous presentation of systemic diseases, infectious disease, and cancer detection and management,” said Brittany.
Serving as a dermatology research fellow, Brittany’s role was to obtain data through chart reviewing, EMR systems, and analysis of patients diagnosed with basal cell carcinomas, squamous cell carcinomas, and cutaneous melanomas. After comparing these findings, her team discovered that patients were not diagnosed with these malignancies in 2020 as they were in 2019. This led to the conclusion that their diagnosis delayed and explained why patients being admitted with further advanced cutaneous malignancies.
In the future, Brittany aspires to specialize in dermatology with a focus on patients of color, “I have noticed that there is a lack of focus on patients of color within the world of dermatology. Patients of color often present differently than those who are not patients of color and have different treatment regimens. I would also like to focus on patients of color with pigmentary disorders and developing patient-centered treatment regimens.
The information and material contained in this article and on this website are for informational purposes only and should not be considered, or used in place of, professional medical advice. Please speak with a licensed medical provider for specific questions or concerns. Ross Med is not responsible for the information maintained or provided on third-party websites or external links.
